Full Year 2023 Somnomed Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the SomnoMed Limited FY '23 Full Year Results and Capital Raising Conference Call. I would now like to turn the conference over to Mr. Neil Verdal-Austin, CEO and Managing Director. Please go ahead.
Thank you very much, and good afternoon to you all, and thanks for attending this webinar conference call to cover our release made this morning to cover both the FY of '23 results and our announcement of an accelerated rights issue and placement to raise $15.5 million. Moving on to Slide 2. This really restates our very clear vision and mission. The vision is patient-centric and our mission is with the help of all industry players and partners to advance the treatment of oral appliances in the world of obstructive sleep apnea.
Slide 3 simply just covers our agenda for this call and presentation. So on to Slide 5, the financial highlights for FY '23. We achieved revenues of $83.6 million, up 15%, just on our revised revenue
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
